USING A PANEL SURVEY TO IDENTIFY PREDICTORS OF DISEASE-MODIFYING DRUG ADHERENCE IN PATIENTS WITH MULTIPLE SCLEROSIS

被引：2
|
作者：
Phillips, A. L. [1 ]
Kozma, C. M.
Locklear, J. C. [1 ]
机构：
[1] EMD Serono Inc, Rockland, MA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.910
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND56
引用
收藏
页码：A400 / A400
页数：1
相关论文
共 50 条
  • [31] Adherence to disease-modifying therapies among patients with multiple sclerosis in Bulgaria - A real world study
    Seitaridou, Yoana
    Chamova, Teodora
    Kamusheva, Maria
    PHARMACIA, 2024, 71 : 1 - 7
  • [32] Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis
    Li, Pengxiang
    Ladage, Vrushabh P.
    Berger, Joseph
    Chahin, Salim
    Jhaveri, Mehul
    Geremakis, Caroline
    Doshi, Jalpa A.
    VALUE IN HEALTH, 2020, 23 (03) : 328 - 334
  • [33] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Hiangkiat Tan
    Qian Cai
    Sonalee Agarwal
    Judith J. Stephenson
    Siddhesh Kamat
    Advances in Therapy, 2011, 28 : 51 - 61
  • [34] Measuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosis
    Lafata, Jennifer Elston
    Cerghet, Mirela
    Dobie, Elizabeth
    Schultz, Lonni
    Tunceli, Kaan
    Reuther, Jacqueline
    Elias, Stanton
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2008, 48 (06) : 752 - 757
  • [35] THE ASSOCIATION OF ADHERENCE TO DISEASE-MODIFYING DRUGS AND OUTOF-POCKET COSTS IN PATIENTS WITH MULTIPLE SCLEROSIS
    Mayer, L.
    Smrtka, J. M.
    Gupta, S.
    Phillips, A. L.
    VALUE IN HEALTH, 2016, 19 (07) : A434 - A435
  • [36] Adherence to Disease-Modifying Agents among Patients with Multiple Sclerosis: 5 Year Prospective Study
    Cerghet, Mirela
    Elias, Stanton
    Dobie, Liz
    Salloum, Ramzi
    Elston-Lafata, Jennifer
    Schultz, Lonni
    NEUROLOGY, 2011, 76 (09) : A72 - A73
  • [37] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [38] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Tan, Hiangkiat
    Cai, Qian
    Agarwal, Sonalee
    Stephenson, Judith J.
    Kamat, Siddhesh
    ADVANCES IN THERAPY, 2011, 28 (01) : 51 - 61
  • [39] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [40] ADHERENCE TO DISEASE-MODIFYING TREATMENTS IN PATIENTS WITH ACTIVE AND NONACTIVE PROGRESSIVE MULTIPLE SCLEROSIS IN THE UNITED STATES
    Chen, J.
    Watson, C.
    Thirumalai, D.
    Barlev, A.
    Jones, E.
    Bogdanovich, S.
    Kresa-Reahl, K.
    VALUE IN HEALTH, 2023, 26 (06) : S333 - S333
12345